UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | J | K | L | M | P | R | S | T | V | W
Number of items: 68.

A

Arulampalam, THA; Costa, DC; Loisidan, M; Visvikis, D; Taylor, I; Ell, PJ; (2000) Positron emission tomography in colorectal cancer. British Journal Of Surgery , 88 pp. 1-14.

Arulampalam, THA; Lovett, B; Loizidou, M; Costa, DC; Boulos, PB; Ell, PJ; Taylor, I; (2000) The role of positron emission tomography in the management of recurrent colorectal cancer. In: (pp. 837-).

B

Becker, W; Bergstroem, K; Carrio, I; Chatal, JF; Corstens, F; Eary, J; Ell, PJ; (2000) Erratum: Nuclear medicine in the next decade (European Journal of Nuclear Medicine (2000) 27 (1277-1279)). European Journal of Nuclear Medicine , 27 (9) 1436-. 10.1007/s002590000356.

Boulos, PB; Lees, WR; Gillams, A; (2000) What is the role of imaging in the management of colorectal cancer? In: Current Challenges in Colorectal Surgery. (pp. 144-167). W B Saunders: London.

Bressan, RA; Mulligan, RS; Costa, DC; Jones, HM; Ell, PJ; Kerwin, RW; Pilowsky, LS; (2000) Striatal D-2 blockade and depression in schizophrenia - SPET findings. Presented at: Biological Psychiatry.

C

Chatterjee, R; Gemidjidglu, ME; Helal, MA; Cullum, I; Poter, JB; (2000) Longitudinal study to evaluate the association between hypogonadism and severity of osteoporosis in homozygous B-thalassemia. In:

Colville-Nash, PR; Gilroy, DW; (2000) COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation? Prostaglandins Other Lipid Mediat. , 62 (1) pp. 33-43.

Colville-Nash, PR; Gilroy, DW; (2000) Cyclooxygenase enzymes as targets for therapeutic intervention in inflammation. Drug News Perspect. , 13 (10) pp. 587-597.

D

Day, R; Mitchell, T; Knight, S; Forbes, A; (2000) Suppression of epithelial syndecan-1 expression by tumor necrosis factor-A. GASTROENTEROLOGY , 118 (4) A806-A806.

Day, R; Mitchell, T; Knight, S; Forbes, A; (2000) Suppression of epithelial syndecan-1 expression by tumour necrosis factor alpha. Presented at: Digestive Disease Week.

Divoli, A; Ott, RJ; Erlandsson, K; Flower, MA; Mériaux, S; (2000) Backprojection-space 3D scatter correction for the PETRRA positron camera. IEEE Nuclear Science Symposium and Medical Imaging Conference , 2

E

Ell, PJ; (2000) Brain SPET. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Impact of European Societies. Seminars in Nuclear Medicine , 3 pp. 225-230.

Ell, PJ; (2000) Medicina Nuclear: O Futuro. Revista Esp Medicina Nuclear , 19 pp. 82-84.

Ell, PJ; (2000) Nuclear Medicine - perspectives and strategy. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Nuclear Medicine in Oncology. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Nuclear medicine: An exciting past and a stimulating future. European Journal of Nuclear Medicine and Molecular Imaging , 27 (SUPPL. 1)

Ell, PJ; (2000) Nuclear medicine: An exciting past and a stimulating future. European Journal of Nuclear Medicine , 27 (1 SUPPL.)

Ell, PJ; (2000) Nuclear medicine: an exciting past and a stimulating future. European Journal of Nuclear Medicine , 27 pp. 55-57.

Ell, PJ; (2000) PET for the few or for the many. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Radiopharmaceuticals and particle size. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Research opportunities in Nuclear Medicine. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Sentinel lymph node detection and imaging. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Sentinel lymphknoten. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Strategies and policies for the advancement of Nuclear Medicine. Presented at: UNSPECIFIED.

Ell, PJ; (2000) What do I expect from a scientific paper. Presented at: UNSPECIFIED.

Ell, PJ; (2000) The devil is in the details - optimum Nuclear Medicine support. Presented at: UNSPECIFIED.

Ell, PJ; (2000) The role of PET in clinical oncology. Presented at: UNSPECIFIED.

Ell, PJ; (2000) Nuclear medicine and cardiology. In: Silverman, HE and Fleming, PR and Hollman, A and Julian, DG and Krikler, DM, (eds.) British Cardiology in the 20th Century. (pp. 155-159). Springer

Erlandsson, K; Visvikis, D; Waddington, WA; Cullum, I; Jarritt, PH; Pilowsky, LS; (2000) Low-statistics reconstruction with AB-EMML. IEEE Nuclear Science Symposium and Medical Imaging Conference , 2

Erlandsson, K; Visvikis, D; Waddington, WA; Jarritt, P; (2000) Truncation reduction in fan-beam transmission scanning using the radon transform consistency conditions. IEEE Transactions on Nuclear Science , 47 (3 PART 3) pp. 989-993.

G

Gilroy, DW; Colville-Nash, PR; (2000) New insights into the role of COX 2 in inflammation. J.Mol.Med. , 78 (3) pp. 121-129.

H

Hutton, B; (2000) Setting the record straight. ANZ Nuclear Medicine , 31 (4) 197-.

Hutton, BF; Kyme, A; Lau, YH; Skerrett, DW; Fulton, RR; (2000) A hybrid 3d reconstruction/registration algorithm for correction of head motion in emission tomography. In:

Hyde, N; Prvulovich, E; Newman, L; Waddington, WA; Keshtgar, MRS; Visvikis, D; Ell, PJ; (2000) Sentinel node imaging / biopsy and 18F-FDG PET for staging the neck in oral squamous cell carcinoma. Presented at: UNSPECIFIED.

Hyde, N; Prvulovich, E; Waddington, WA; Keshtgar, MRS; Newman, L; Ell, PJ; (2000) Comparative study of sentinel lymph node imaging / biopsy and 18F-FDG PET in oral cancer staging. Presented at: UNSPECIFIED.

J

Jones, HM; Travis, MJ; Mulligan, RS; Bressan, RA; Visvikis, D; Gacinovic, S; Ell, PJ; (2000) 5-HT2A receptor blockade by quetiapine is related to its side effect profile. Presented at: Biological Psychiatry.

Jones, HM; Travis, MJ; Mulligan, RS; Visvikis, D; Gacinovic, S; Ell, PJ; Kerwin, RW; (2000) In vivo serotonin 5-HT2A receptor occupancy and quetiapine. American Journal of Psychiatry , 157 1-.

K

Keshtgar, MRS; Ell, PJ; (2000) Sentinel lymph node biopsy in breast carcinoma. In: Taylor, J, (ed.) Recent Advances in Surgery. (pp. 109-123). Churchill Livingstone

Keshtgar, MRS; Kocjan, G; Davidson, T; Ralphs, D; Taylor, I; Ell, PJ; (2000) Touch imprint cytology and the sentinel node in breast carcinoma. In: (Proceedings) Sentinel Node 2000.

L

Leonard, AJ; Evans, IM; Pickard, MR; Sinha, AK; Ekins, RP; (2000) Maternal hypothyroidism and feto-placental nuclear 3,5,3' triiodothyronine binding. Presented at: Abstract of oral and poster presentation at British Thyroid Association meeting.

Lythgoe, MF; Thomas, DL; Calamante, F; Pell, GS; King, MD; Busza, AL; Sotak, CH; (2000) Acute changes in MRI diffusion, perfusion, T<inf>1</inf>, and T<inf>2</inf> in a rat model of oligemia produced by partial occlusion of the middle cerebral artery. Magnetic Resonance in Medicine , 44 (5) pp. 706-712. 10.1002/1522-2594(200011)44:5&lt;706::AID-MRM8&gt;3.0.CO;2-1.

M

Martin, J; (2000) The idea is more important than the experiment. The Lancet , 356 pp. 934-937.

McGrath, S; Bouloux, PMG; (2000) Adrenogenital syndrome. In: Fink, G, (ed.) Encyclopedia of Stress. (pp. 75-80). Academic Press

P

Pike, VW; Mulligan, RS; Halldin, C; Nobuhara, K; Hiltunen, J; Swahn, CG; Karlsson, P; (2000) [I-123]SB 207710 exhibits 5-HT4 receptor-selective binding in monkey brain in vivo. Presented at: Journal of Nuclear Medicine.

R

Randeva, H; Bouloux, PMG; (2000) Cushing's Syndrome. Student BMJ , 8 pp. 100-104.

Randeva, H; Bouloux, PMG; (2000) Thyrotoxicosis. Student BMJ , 8 pp. 62-64.

Robertson, A; MacColl, G; Bouloux, PMG; (2000) Mechanism of anosmin-1 cleavage in vitro. Journal of Endocrinology , 164 (Suppl) 175-.

Rogers, DPS; Bouloux, PMG; Vanderpump, MPJ; (2000) Cytokine-mediated reversible hypopituitarism in POEMS syndrome. Journal of Endocrinology , 164 (Suppl) 28-.

S

Sampson, D; Pickard, M; Evans, IM; Sinha, AK; Ekins, RP; (2000) Maternal Thyroid Status Regulates the Expression of Neuronal and Astrocytic Cytoskeletal Proteins in the Fetal Brain. Abstract of oral presentation at the 19th Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine Soci. Presented at: UNSPECIFIED.

Selwood, D; Zachary, I; (2000) VEGF PEPTIDES AND THEIR USE FOR INHIBITING ANGIOGENESIS. WO0234767.

Soares, AJ; Cullum, I; Miller, DJ; Royle, GJ; Speller, RD; (2000) Development of a wavelength shifting fibre gamma camera. Presented at: IEEE Transactions on Nuclear Science.

Stephenson, CME; Bigliani, VB; Jones, HM; Mulligan, RS; Acton, PD; Visvikis, D; Ell, PJ; (2000) Striatal and extra-striatal D2/D3 dopamine receptor occupancy by quetiapine in vivo [123I] epidepride SPET study. The British Journal of Psychiatry , 177 pp. 408-415.

T

Taylor, LG; Farquharson, M; Cullum, I; Prvulovich, E; (2000) Quantitative comparison of OS-EM iterative and filtered backprojection reconstruction techniques for 201Thallium myocardial perfusion SPECT. Presented at: UNSPECIFIED.

Taylor, LG; Farquharson, M; Cullum, I; Prvulovich, E; (2000) Semi-quantitative comparison of OS-EM iterative and FBP algorithms for 201Thallium myocardial SPECT. Presented at: UNSPECIFIED.

Thomas, DL; Lythgoe, MF; Pell, GS; Clamante, F; Ordidge, RJ; (2000) Topical Review: The measurement of diffusion and perfusion in biological sytems using magnetic resonacne imaging. Physics in Medicine Biology , 45 pp. 97-138.

Travis, MJ; Mulligan, RS; Waddington, W; Erlandsson, K; Visvikis, D; Matthiasson, P; Costa, DC; (2000) The test/retest stability of in vivo single photon emission tomography (SPET) estimates of cortical 5-HT2(A) receptors. Presented at: UNSPECIFIED.

Travis, MJ; Visvikis, D; Erlandsson, K; Mulligan, R; Matthiasson, P; Waddington, W; Costa, DC; (2000) Displacement of the selective 5-HT2A ligand I-123-5-I-R91150 by unlabelled ketanserin. Presented at: UNSPECIFIED.

Travis, MJ; Visvikis, D; Erlandsson, K; Mulligan, RS; Waddington, WA; Matthiasson, P; Pilowsky, LS; (2000) Dynamic displacement of the selective 5-HT2A receptor ligand I-123-5-I-R91150 by unlabelled ketanserin. Presented at: Journal of Nuclear Medicine.

Travis, MJ; Visvikis, D; Erlandsson, K; Waddington, WA; Mulligan, RS; Matthiasson, P; Pilowsky, LS; (2000) The reproducibility of in vivo single photon emission tomography (SPET) estimates of cortical 5-HT2A receptors. Presented at: Journal of Nuclear Medicine.

Trontzos, CA; Ramon, B; Gacinovic, S; Costa, DC; (2000) Quantitative analysis of brain perfusion SPET studies: A simplified intra-and inter-observer comparative study. Hellenic Journal of Nuclear Medicine , 3 (1) pp. 44-49.

V

Visvikis, D; Travis, MJ; Erlandsson, K; Ell, PJ; (2000) Simplified reference tissue model for parametric imaging of 123I-5-R91150: A SPET ligand for 5HT2A receptors. Presented at: UNSPECIFIED.

Visvikis, D; Travis, MJ; Erlandsson, K; Waddington, WA; Jarritt, PH; Ell, PJ; (2000) Parametric imaging of 5HT2A receptors using 123I-5-I-R91150 and SPET. Presented at: UNSPECIFIED.

W

Waddington, WA; Keshtgar, MRS; Ell, PJ; (2000) Does early, dynamic imaging increase the accuracy of sentinel lymph node imaging for breast cancer? Presented at: Sentinel Node 2000 Meeting.

Walker, Z; Costa, DC; Walker, RWH; Gacinovic, S; Shaw, K; Stevens, T; Livingstone, G; (2000) Dementia with Lewy bodies: Preliminary data on clinical, pathological and FP-CIT SPET correlations. Presented at: UNSPECIFIED.

Walker, Z; Costa, DC; Walker, RWH; Gacinovic, S; Shaw, K; Stevens, T; Livingstone, G; (2000) In vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies using 123I-FP-CIT SPET. Presented at: UNSPECIFIED.

White, LL; Ott, RJ; Flower, MA; Erlandsson, K; Duxbury, DM; Bruyndonckx, P; Tavernier, S; (2000) Preliminary evaluations of high resolution positron emission tomography for breast imaging. IEEE Nuclear Science Symposium and Medical Imaging Conference , 3

Willoughby, DA; Moore, AR; Colville-Nash, PR; Gilroy, D; (2000) Resolution of inflammation. Int.J.Immunopharmacol. , 22 (12) pp. 1131-1135.

This list was generated on Sun Dec 4 04:20:13 2016 GMT.